Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|February 24, 2001
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA studyA Mocroft, A N Phillips, V Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 9, 1997
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study GroupJ D Lundgren, A N Phillips, S Vella, et al.
HIV Medicine|June 22, 2010
Late presentation of HIV infection: a consensus definitionA Antinori, T Coenen, D Costagiola, et al.
HIV Medicine|February 24, 2006
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wastingJ Gold, M J Batterham, H Rekers, et al.
HIV Medicine|July 14, 2017
Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) studyS L Pett, J Amin, A Horban, et al.
HIV Medicine|October 25, 2019
The EuroSIDA study: 25 years of scientific achievementsK Laut, O Kirk, J Rockstroh, et al.
Pageof 3